For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251231:nRSe3254Na&default-theme=true
RNS Number : 3254N Minoan Group PLC 31 December 2025
The information contained within this announcement is deemed to constitute
inside information as stipulated under the Market Abuse Regulation (EU) No.
596/2014, which is part of UK law by virtue of the European Union (withdrawal)
Act 2018. Upon the publication of this announcement, this inside information
is now considered to be in the public domain.
31 December 2025
Minoan Group Plc
(the "Company" or "Minoan")
Results of General Meeting
The Board of Minoan Group Plc announces that at the General Meeting held
yesterday resolution 1 was duly passed. The disposal of Loyalward Limited (the
'Disposal') has completed.
The vote on Resolution 2 was adjourned and the Board will make an announcement
on this matter in due course.
As previously announced, following the Disposal, the Board estimates that the
Company will be left with sufficient funds to continue to operate for
approximately 2 to 3 months whilst covering essential expenses and exploring
legal action against the former Chairman. The Board does not consider that
this is sufficient time during which to resolve the unsettled creditors and
raise additional funds and therefore it is not able to clarify the Company's
financial position and to apply to have the Company's shares restored to
trading on AIM. As a result, the Board expects that the Company's admission to
trading on AIM will be cancelled at 7 a.m. on 5 January.
For further information visit www.minoangroup.com
(http://www.minoangroup.com/) or contact:
Minoan Group Plc mail@minoangroup.com
Zeus
Antonio Bossi / Andrew De Andrade 020 3829 5000
Peterhouse Capital Limited
Duncan Vasey 020 7469 0930
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END ROMPKDBKDBDDPBN
Copyright 2019 Regulatory News Service, all rights reserved